BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 5:12:00 PM | Browse: 844 | Download: 733
Publication Name World Journal of Gastroenterology
Manuscript ID 7184
Country United States
Received
2013-11-07 14:12
Peer-Review Started
2013-11-08 16:17
To Make the First Decision
2013-12-16 18:10
Return for Revision
2013-12-20 17:44
Revised
2014-01-08 04:24
Second Decision
2014-04-16 11:23
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-16 12:11
Articles in Press
2014-05-23 09:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-06-26 18:14
Publish the Manuscript Online
2014-07-21 17:17
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Randomized Clinical Trial
Article Title Routine use of thiopurines in maintaining remission in pediatric Crohn’s disease
Manuscript Source Invited Manuscript
All Author List Brendan M Boyle, Michael D Kappelman, Richard B Colletti, Robert N Baldassano, David E Milov and Wallace V Crandall
Funding Agency and Grant Number
Corresponding Author Brendan M Boyle, MD, MPH, Nationwide Children’s Hospital, 700 Children’s Drive, Columbus, OH 43205, United States. brendan.boyle@nationwidechildrens.org
Key Words Crohn’s disease; Pediatric; Remission; Thiopurines; Mercaptopurine
Core Tip This manuscript describes the real world effectiveness of thiopurines in maintaining remission for pediatric Crohn’s disease. The outcomes differ in comparison to the initially published randomized controlled trial for pediatric Crohn’s but are similar to more recently published studies evaluating the effectiveness of thiopurines. The study evaluates data from a pediatric inflammatory bowel disease registry and is representative of real world clinical care. Varitation in practitioner approach to thiopurine dosage and metabolite measurement was found. Implementation of a more standardized approach to use of thiopurines could impact clinical outcomes.
Publish Date 2014-07-21 17:17
Citation Boyle BM, Kappelman MD, Colletti RB, Baldassano RN, Milov DE, Crandall WV. Routine use of thiopurines in maintaining remission in pediatric Crohn’s disease. World J Gastroenterol 2014; 20(27): 9185-9190
URL http://www.wjgnet.com/1007-9327/full/v20/i27/9185.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i27.9185
Full Article (PDF) WJG-20-9185.pdf
Full Article (Word) WJG-20-9185.doc
Manuscript File 7184-Review.doc
Answering Reviewers 7184-Answering reviewers.pdf
Copyright License Agreement 7184-Copyright assignment.pdf
Peer-review Report 7184-Peer reviewer(s).pdf
Scientific Editor Work List 7184-Scientific editor work list.doc